|
Reference : Immortal time bias and infliximab-related mortality and malignancy incidence |
|
| | |
| | Scientific journals : Letter to the editor | |
| | Human health sciences : Gastroenterology & hepatology
| |
| | http://hdl.handle.net/2268/38935 | |
| | |
| Immortal time bias and infliximab-related mortality and malignancy incidence |
| English |
| Fidder, H. [ > > ] |
| Van Steen, Kristel [Université de Liège - ULg > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique >] |
| Van Assche, G. [ > > ] |
| Rutgeerts, P. [ > > ] |
| Vermeire, S. [ > > ] |
| 2010 |
| Gut |
| BMJ Group |
| 59 |
| 416 |
| International |
| 0017-5749 |
| 1458-3288 |
| London |
| United Kingdom |
| http://hdl.handle.net/2268/38935 |
| File(s) associated to this reference | |
|
Fulltext file(s):
| |
| | |
All documents in ORBi are protected by a user license.